<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article162</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/AKIKI" style="display:block; margin-bottom:10px;">AKIKI Original</a></li>
<h2><strong>AKIKI</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Timing of Renal Replacement Therapy in Acute Kidney Injury". The New England Journal of Medicine. 2016.<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In critically ill patients with severe acute kidney injury, does early initiation of renal replacement therapy improve survival compared to delayed initiation?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In critically ill patients with severe acute kidney injury, early versus delayed initiation of renal replacement therapy showed no significant difference in mortality.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
The optimal timing of RRT initiation in critically ill patients with AKI remains uncertain, as current guidelines have heterogeneous criteria for RRT initiation and highlight the need for further research.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized, open-label, two-group trial<br/>
- N=620 patients <br/>
- Early-strategy group (n=312)<br/>
- Delayed-strategy group (n=308)<br/>
- Setting: 31 intensive care units in France<br/>
- Enrollment: September 2013 to January 2016<br/>
- Primary outcome: Overall survival at day 60<br/>
- Randomized within 5 hours after reaching stage 3 AKI<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
- Adults (â‰¥18 years) admitted to ICU with severe AKI (KDIGO stage 3)<br/>
- Required mechanical ventilation, catecholamine infusion, or both<br/>
- Excluded if immediate life-threatening complications from renal failure were present<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Early-strategy: Initiate RRT immediately after randomization<br/>
- Delayed-strategy: Initiate RRT only upon developing severe hyperkalemia, metabolic acidosis, pulmonary edema, BUN &gt;112 mg/dL, or oliguria persisting more than 72 hours post-randomization<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
- Overall mortality at day 60: 48.5% early-strategy vs. 49.7% delayed-strategy (P=0.79)<br/>
- 49% in delayed-strategy group did not receive RRT<br/>
- Higher rate of catheter-related bloodstream infections in the early-strategy group (10% vs. 5%; P=0.03)<br/>
- Faster recovery of renal function in the delayed-strategy group (P&lt;0.001)<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Study may be underpowered to detect small differences in mortality.<br/>
- Majority of patients received intermittent hemodialysis, limiting generalizability.<br/>
- Patients had advanced AKI, thus results may not apply to all KDIGO stages of AKI.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Funded by the French Ministry of Health.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
ClinicalTrials.gov number, NCT01932190.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
